Loading chat...

MO SB1767

Bill

Status

Introduced

2/26/2026

Primary Sponsor

Rick Brattin

Click for details

Origin

Senate

2026 Regular Session

AI Summary

  • Veterans and first responders age 21+ with PTSD, major depressive disorder, substance use disorders, or end-of-life care needs would be exempt from state criminal penalties for therapeutic psilocybin use, provided they enroll in a study, obtain physician documentation, use a licensed facilitator, have the substance lab-tested, and limit use to 150mg annually

  • Facilitators must hold specified healthcare licenses (physician, psychologist, licensed clinical social worker, nurse practitioner, etc.) and complete at least 30 hours of psilocybin-specific training consistent with American Psychological Association or American Psychedelic Practitioners Association guidelines

  • Department of Mental Health would receive $2 million in grants for psilocybin research and must conduct a study with university hospitals or FDA-approved contract research organizations on psilocybin efficacy for veterans and first responders

  • Existing "Right to Try" law (Section 191.480) would be expanded to cover life-threatening and severely debilitating conditions, not just terminal illness, and would remove the exclusion of Schedule I controlled substances from investigational drug access

  • Healthcare providers and physicians participating in psilocybin therapy or studies would be protected from criminal/civil liability and professional license discipline, except in cases of gross negligence or willful misconduct

Legislative Description

Modifies provisions relating to alternative therapies and treatments, including psilocybin

Last Action

S First Read

2/26/2026

Full Bill Text

No bill text available